2Joos. K. M, Bueche. M. J, Palmberg. P. F, et al. Oneyear follow- up results of combined mitomycin C trabeeular and extracapsular cataract extraction. Ophthalmology, 1995, 102:76-83.
3Panda. Anita, Bajaj. Mandeeps, Balasubramanya. R. Topical mitomycin C for conjunctival corneal squamous cell carcinoma. Am J Ophthalmology, 2003, 133:122-123.
4Francesco Carones, Luca Vigo, Elena Scandola. Evaluation of the prophylactic use of mitomycin C to inhibit haze formation after photorefractive keratectomy. J Cataract Refract Surg, 2002, 28:2089 - 2095.
5Stojanovic A, Nitter TA. 200 Hz flying - spot technologyof the LaserSight LSX excimer laser in the treatment of myopic astigmatism; six and 12 month outcomes of laser in situ keratomileusis and photorefractive keratectomy. J Caratact Refract Surg, 2001, 27:1263 - 1277.
6Rashad KM. Laser in situ keratomileusis for myopic astigmatism. J Refract Surg, 1999, 15:653-660.
7Talamo JH, Gollamudi S, Green WR, et al. Modulation of corneal wound healing after excimer laser keratomileusis using topical mitomycin C and steroids. Arch Ophthalmol, 1991, 109:1141 - 1146.
8H. Mehrdad Sadeghi, Berthold Seitz, Seiji Hayashi, et al. In vivro effects of Mitomycin- c human keratocytes. J Refract Surg,1998, 14:534-540.
9Lee JB. Comparison of laser epithelial keratomileusis and photorefractive keratectomy for low to moderate myopia[J]. J Cataract Refract Surg 2001 ;27:565-570.
